From: Kinetic changes in virology, specific antibody response and imaging during the clinical course of COVID-19: a descriptive study
Lobes involved
Moderate (n = 12)
Severe (n = 2)
N (%)
Single lobe
2 [6, 14]
0
2 (14.3)
Two-lobe
5 [3, 4, 7, 12, 13]
5 (35.7)
Three-lobe
3 [5, 10, 11]
3 (21.4)
Four-lobe
1 [9]
1 (50%) [16]
Five-lobe
1 [8]
1 (50%) [17]